Ulipristal acetate in emergency contraception.

Area of Science:

• Reproductive Health
• Pharmacology

Background:

• Unintended pregnancies pose significant health, social, and economic challenges.
• Emergency contraception pills (ECP) offer a method to prevent pregnancy after unprotected intercourse.

Purpose of the Study:

• To provide a literature review of ulipristal acetate (UPA) and its role in emergency contraception.
• To highlight UPA's efficacy and pharmacological profile as a selective progesterone modulator.

Main Methods:

• Literature review of studies on ulipristal acetate for emergency contraception.
• Analysis of UPA's mechanism of action, including its effects on ovulation.

Main Results:

• Ulipristal acetate is a synthetic selective progesterone modulator, acting as an antagonist and partial agonist at the progesterone receptor.
• UPA is recognized as a highly effective emergency contraceptive pill, preventing pregnancy by delaying or inhibiting ovulation.
• Clinical evidence supports UPA's superior efficacy, leading to its recommendation as a first-line prescription choice.

Conclusions:

• Emergency contraception pills, including ulipristal acetate, are not abortifacients as they do not interfere with post-fertilization events.
• Ulipristal acetate represents a significant advancement in emergency contraception due to its high efficacy and favorable pharmacological profile.
• UPA is recommended as a first-choice emergency contraceptive for women of all ages, irrespective of the time after intercourse.